Welcome to our dedicated page for Sundance Strategies SEC filings (Ticker: SUND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Sundance Strategies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Sundance Strategies's regulatory disclosures and financial reporting.
Sundance Strategies, Inc. files its annual report describing a highly specialized business around life settlements and related advisory services. The company historically focused on indirect rights to net insurance benefits from portfolios of life insurance policies and is now building a professional services platform for structured finance and bond offerings tied to life settlements.
The filing emphasizes that operations have consumed significant cash, depend heavily on continued debt and equity financing, and could be scaled back or become insolvent without new capital. As of June 29, 2026, Sundance had 43,063,441 common shares outstanding, with a large portion beneficially owned by executives, directors, and major stockholders, leading to concentrated control. Extensive risk factors highlight regulatory uncertainty, reliance on a single MRI provider, illiquidity in life settlement markets, model and longevity risk, and substantial legal and privacy exposures.
Sundance Strategies, Inc. reported another quarter without investment income and a net loss of $220,708 for the three months ended December 31, 2025, and $1,019,322 for the nine months. Operating costs were modest, with general and administrative expenses of $110,504 for the quarter and $341,057 year-to-date.
The company remains highly leveraged, with total liabilities of $6,984,624 against total assets of $53,787, resulting in a stockholders’ deficit of $6,930,837. Cash declined to $40,287 from $168,648 at March 31, 2025, while management cites average monthly operating expenses of about $40,000.
Debt financing, largely from related parties, continues to underpin liquidity. As of December 31, 2025, the company cites availability of $115,000 on notes payable, $4,257,253 on related-party lines of credit, and $3,000,000 under an 8% convertible debenture agreement. Management believes these resources will fund operations for at least 12 months. A total of 14,126,255 warrants were outstanding, and subsequent extensions of related-party notes in January 2026 generated additional warrants. Disclosure controls and procedures were deemed not effective, with remediation efforts focused on complex equity-based compensation accounting.
Sundance Strategies (SUND) reported Q2 FY2026 results showing a small operating profile supported by related‑party credit. For the quarter ended September 30, 2025, the company posted a net loss of $190,620 (six‑month net loss $798,614). General and administrative expenses were $99,789 in the quarter, and interest expense was $90,831.
Liquidity tightened: cash was $484 at September 30, 2025, versus $168,648 at March 31, 2025. Cash used in operations was $193,164 for the six months. Management cites access to additional borrowing capacity of $275,000 on notes payable, $4,265,942 on related‑party facilities, and $3,000,000 under an 8% convertible debenture, with average monthly operating expenses around $40,000.
The balance sheet shows total liabilities of $6,731,260 and a stockholders’ deficit of $(6,713,211). During the period, the company issued 1,399,508 warrants (valued at $388,511) tied to debt extensions; 15,464,631 warrants were outstanding at quarter‑end, with 1,355,754 expiring in October. Disclosure controls were deemed not effective. Common shares outstanding were 43,063,441 as of November 13, 2025.